The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 0 (Ph0) and Window-of-Opportunity (WoO) trial quality and reporting.
 
Omar Farooq Khan
Stock and Other Ownership Interests - Celgene
 
Sunil Parimi
Honoraria - Amgen; Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer
 
Hatim Karachiwala
No Relationships to Disclose
 
Yongtao Lin
No Relationships to Disclose
 
Jose Gerard Monzon
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Merck; Shire
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Amgen
 
Vincent C. Tam
Honoraria - Apobiologix; Celgene
Travel, Accommodations, Expenses - Amgen
 
Eric Chen
Honoraria - Merck; Roche Canada; Taiho Pharmaceutical
Research Funding - AstraZeneca; Boston Biomedical; Bristol-Myers Squibb
 
Janet Dancey
Leadership - 3Ci
Honoraria - 3Ci
Consulting or Advisory Role - Roche Canada
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Patricia A. Tang
Consulting or Advisory Role - AMGEN; Celgene; Genomic Health International; Merck; Novartis Canada Pharmaceuticals Inc; Shire; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen